Moxetumomab Pasudotox vs Osimertinib

## Moxetumomab Pasudotox vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Moxetumomab Pasudotox** and **Osimertinib**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Moxetumomab Pasudotox — N/A; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Moxetumomab Pasudotox — N/A; Osimertinib — C28H33N7O2.

**Molecular Weight**: Moxetumomab Pasudotox — N/A; Osimertinib — 499.6050 g/mol.

**Type**: Moxetumomab Pasudotox — Antibody drug conjugate; Osimertinib — Small molecule.